Diabetes mellitus is a common metabolic disease characterized by impaired insulin secretion, insulin resistance, and chronic hyperglycemia. While pharmacological treatments remain essential, plant-derived products have garnered considerable interest in recent times. This attention stems from their capacity to demonstrate broad biological activity coupled with a generally reduced risk of side effects. This review examines the antidiabetic potential of ginger (Zingiber officinale), clove (Syzygium aromaticum), and dandelion (Taraxacum officinale). Literature findings suggest that these plants may exert hypoglycemic effects through various mechanisms, including suppression of activity α-amylase and α-glucosidase, stimulation of insulin secretion, and reduction of oxidative stress and inflammation. Although results from laboratory studies and animal models are promising, clinical studies are limited. Current data suggest that these plants may play a complementary and supportive role in diabetes management. Extensive human-based investigations are still necessary to verify the long-term safety profile and therapeutic efficacy of these compounds.
Şanli et al. (Mon,) studied this question.